This activity will bring a leading clinical investigator to your cancer center to discuss emerging data on PARP inhibitors that can rationally inform the management of ovarian cancer. Enroll your institution today!
This live activity will bring a leading clinical investigator to your cancer center to discuss emerging data in treatment selection and supportive care for patients with previously untreated and relapsed/refractory FL. Enroll your institution today!